Skip to content

Prestige Consumer Healthcare

US · PBH #2733 by market cap Listed 1970
49.63 +0.03 +0.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Oppenheimer moved from Buy to Hold on 2026-05-14.

Analyst consensus 1 analysts

Buy
Avg price target 70.00 +41.0%
Price target rangecurrent 49.63
Low70.00
Avg70.00
High70.00
Buy 100% Hold 0% Sell 0%
Recent ratings (23)
DateFirmAnalystRatingTarget
2026-11-06 CCORF -- Buy 70.00
2026-08-06 CCORF -- Buy 72.00
2026-08-06 William Blair -- Buy --
2026-06-01 CCORF -- Buy 72.00
2026-05-15 CCORF -- Buy 72.00
2026-05-14 Oppenheimer -- Hold --
2026-05-13 William Blair -- Buy --
2026-05-07 Oppenheimer -- Buy 65.00
2026-03-23 CCORF -- Buy 86.00
2026-03-23 William Blair -- Buy --
2026-03-19 RBC Capital -- Buy 91.51
2026-03-17 William Blair -- Buy --
2026-02-23 Oppenheimer -- Buy --
2026-02-11 Oppenheimer -- Buy 77.00
2026-02-06 CCORF -- Buy 86.00
2026-02-05 William Blair -- Buy --
2026-01-30 Jefferies -- Hold 66.00
2026-01-14 CCORF -- Buy 88.00
2026-01-13 William Blair -- Buy --
2026-01-13 Oppenheimer -- Buy --
2025-11-07 CCORF -- Buy 88.00
2025-11-06 William Blair -- Buy --
2025-10-21 Oppenheimer -- Buy 72.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-05-14 Oppenheimer Buy → Hold --

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2027/Q2 2026-11-05 -- ±9.96% -16.82% (beat)
2027/Q1 2026-08-06 -- ±9.31% +2.74% (in line)
2026/Q4 2026-05-13 After close ±9.47% -11.35% (beat)
2026/Q3 2026-02-05 -- ±5.33% -2.21% (in line)
2026/Q2 2025-11-06 -- ±8.48% +2.56% (in line)
2026/Q1 2025-08-07 -- -- -10.05%
2025/Q4 2025-05-08 -- -- +6.92%
2025/Q3 2025-02-06 -- -- +14.78%
2025/Q2 2024-11-07 -- -- +3.16%
2025/Q1 2024-08-08 -- -- -1.55%
2024/Q4 2024-05-14 After close ±3.78% -7.01% (beat)
2024/Q3 2024-02-08 -- ±4.95% +9.36% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Prestige Consumer Healthcare discussion 0 comments

Add a comment